drugset / Trial / NCT02224131

Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling

NCT02224131 ↗

Phase 4 Unknown 1856 enrolled Beijing Tiantan Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Patients' responses to oral antiplatelet therapy are subject to variation. Bedside monitoring offers the opportunity to improve outcomes of intracranial aneurysm patients undergoing stent deployment by individualizing therapy.This trial is designed to demonstrate the superiority of a strategy of platelet function monitoring with dose adjustment in suboptimal responders as compared to a more conventional strategy without monitoring and without dose adjustment to reduce the primary end point evaluated 6 months after stent deployment in patients with intracranial aneurysms.

Timeline

Start
2015-01
Primary completion
2020-06
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 100 mg —
Subject Clopidogrel Small molecule 75 mg —

Indications